Omeros | OMER - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Adma Biologics USD 61.59M 14.07M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cytokinetics USD -183.03M 123.15M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -21.38M 8.2M 2024-06
Insmed USD -326.93M 41.77M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 9.52M 11.45M 2025-09
Pfizer USD 3.33B 290M 2025-09
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06